Search results :


More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: L02BA02

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3
Menopausal symptoms Hot flush postmarketing, 30% - 35% x x x
Hot flush Hot flush postmarketing, 30% - 35% x x x
Hyperhidrosis Sweating postmarketing, 17% - 20% x x x
Nausea Nausea postmarketing, 14% - 15% x x x
Vaginal discharge Vaginal discharge postmarketing, 13% - 16% x
Leukorrhea x x
Dry eye Dry eye 7.44% - 9.05% x
Dizziness Dizziness 7% - 9% x x x
Cataract Cataract 2.49% - 9.95% x
Oedema Oedema 5% x x x
Vomiting Vomiting 2% - 4% x x x
Vaginal haemorrhage Vaginal haemorrhage 2% - 4% x x
Hypercalcaemia Hypercalcaemia 0.637% - 2.79% x x x
Diplopia Diplopia 1.4% x
Visual impairment Abnormal vision 1.4% x
Disorder sight x
Keratopathy Keratopathy 0.93% - 1.81% x
Thrombosis Thrombosis 0.465% - 1.99% x
Arrhythmia Arrhythmia 0.498% - 1.4% x
Thrombophlebitis Thrombophlebitis 0.637% - 1.87% x x
Cardiac failure Cardiac failure 0.465% - 1.49% x
Myocardial infarction Myocardial infarction 0.498% - 1.4% x
Acute coronary syndrome Myocardial infarction 0.498% - 1.4% x
Glaucoma Glaucoma 0.498% - 1.36% x
Pulmonary embolism Pulmonary embolism 0.498% - 1.81% x x
Angina pectoris Angina pectoris 0.467% - 0.995% x
Alopecia Alopecia x x x
Decreased appetite Anorexia x x
Appetite absent x
Arthritis Arthritis x
Asthenia Asthenia x x
Fatigue x x x
Ataxia Ataxia x
Back pain Back pain x
Mental disorder Mental disorder x
Breast disorder Breast disorder x
Chest pain Chest pain x
Constipation Constipation x x x
Corneal opacity Corneal opacity x x x
Cyst Cyst x
Dermatitis Dermatitis x x
Rash x
Dyspnoea Dyspnoea x x x
Endometrial hyperplasia Endometrial hyperplasia x
Rash Rash x
Eye disorder Eye disorder x
Fatigue Fatigue x x x
Gastrointestinal disorder Gastrointestinal disorder x x
Headache Headache x x
Hepatitis toxic Hepatitis toxic x
Jaundice Jaundice x x x
Lethargy Lethargy x
Leukopenia Leukopenia x
Liver disorder Liver disorder x
Hepatocellular injury Liver disorder x
Foetor hepaticus Liver disorder x
Mediastinal disorder Mediastinal disorder x
Metabolic disorder Metabolic disorder x
Nervous system disorder Nervous system disorder x
Pain Pain x
Paresis Paresis x x
Neuropathy peripheral Neuropathy peripheral x
Polyp Polyp x
Pruritus Pruritus x x x
Thrombocytopenia Thrombocytopenia x
Tremor Tremor x x
Uterine haemorrhage Uterine haemorrhage x
Angiopathy Angiopathy x
Vertigo Vertigo x x x
Weight increased Weight increased x x
Mood swings Mood swings x
Affect lability Mood swings x
Deep vein thrombosis Deep vein thrombosis x
Liver function test abnormal Liver function test abnormal x
Skin discolouration Skin discolouration x x
Uterine polyp Uterine polyp x
Malnutrition Malnutrition x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Hepatobiliary disease Hepatobiliary disease x
Vision blurred Vision blurred x
Chills Rigors x
Musculoskeletal stiffness Stiffness x
Endometrial cancer Endometrial cancer x
Coordination abnormal Coordination abnormal x
Embolism Thromboembolic event x x
Endometrial hypertrophy Endometrial hypertrophy x x
Oestrogenic effect Oestrogenic effect x
Insomnia Insomnia x x


Information about indications was extracted from the indications and usage sections of the labels.

toremifene / toremifene

Side effects:44


Side effects:46
Source:FDA Structured Product Label

Color scheme:


    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    no frequency information
    not found on label